Notably, the presence of anti‐tPA antibodies has been documented in some human IBD patients, and development of these antibodies has been proposed as a potential mechanism underlying the observed hypofibrinolytic and prothrombotic state in this population [70]. This evidence concerns the gene PLAT and inflammatory bowel disease.